BREAKING: Largest Real-World Analysis of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Regression After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported no evidence of disease (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization. NICOLAS HULSCHER, MPH APR 07, 2026 by Nicolas Hulscher, MPH We have completed the...
Read More »
July 4th Militarist Bunkum (an encore by request)
July 4th Militarist Bunkum (an encore by request) Paul Craig Roberts Did you know that 85 to 90 percent of